What if you held a tree long enough for it to grow around your hand?” For a piece called It Will Continue to Grow E ...

Propagation is the best way to get fruit trees that yield good fruit and resist disease. Learn three ways to propagate fruit ...

GOLDEN VALLEY, Minn. — Nothing brings winter magic to a backyard quite like a Bird Christmas Tree. It’s festive, sustainable, and gives local birds a nutritious boost during the coldest months. Best ...

Here's how to fill your home with holiday cheer, without a safety hazard Every December, we turn our living rooms into holiday showpieces, some bright enough to make Clark Griswold proud. It’s a ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Preheat the oven to 400 degrees F. Line a baking sheet with parchment paper. Divide the dough into 23 pieces. Roll each piece into a small ball. To make a tree shape: Arrange a row of 6 balls of dough ...

Right about now, households across Britain are trimming their Christmas trees. It's one of the season's simplest pleasures to be had at home: pour a festive tipple, queue up some holiday tunes and ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...